Metallothionein As An Early Biomarker For Death Secondary To Septic Shock And As A Novel Therapeutic Target For Septic Shock
US Patent:
2009013, May 28, 2009
Filed:
Apr 19, 2006
Appl. No.:
11/912091
Inventors:
Hector R. Wong - Cincinnati OH, US Bruce J. Aronow - Cincinnati OH, US Thomas P. Shanley - Ann Arbor MI, US
International Classification:
A61K 33/30, C12Q 1/68, A61K 31/315
US Classification:
424641, 435 6, 514494, 424643
Abstract:
A set of signature genes that predict the severity of septic shock, as well as methods of diagnosing and treating septic shock. The genes and methods are particularly useful for the identification of individuals who are at a high risk of death from septic shock.